Q: Is there a currently available way to objectively determine if lumbrokinase is effective? I am aware of the references available on your web site. I’m just trying to avoid having to read through them to get an answer to the above question.
Jim V. (Undisclosed location)
A: Before you start on lumbrokinase you should make sure that it is right for you, namely if you have a hypercoagulable blood state (an out-of-balance thicker blood). The cheapest screening tests that would indicate that would be C-RP and Fibrinogen. If they are chronically elevated, then you likely have a hypercoagulable blood state. And you can also use them as monitoring markers to see if you are getting better.
However, if they are normal, it does not necessarily mean that you don’t have hypercoagulation. You doctor can run more specific coagulation panels to determine that and also monitor your progress.
Please realize that most people do not just become hypercoagulable over-night. It is most often caused by some sort of chronic inflammatory or infectious processes. Therefore, addressing the underlying issue is the long-term key. Lumbrokinase is a crutch therapy for people who are at risk.
Q: We will be doing the ISAC panel by Esoterix Labs to check for abnormalities in the clotting cascade on a patient. It consists of Fibrinogen activity, prothrombin Fragment 1 + 2, T/AT Complexes, CD62P, Cd62P + ADP and Platelet Activation Index. Also, the Alpha 2 anti-plasmin test. I need to know when we need to stop taking Boluoke® so we don’t influence the test results. Susan O., RN (Seattle, WA)
A: If you are looking to see if the current dose of Boluoke® is providing sufficient protection for your patient, then there’s is no need to stop Boluoke®. If you are looking to see the baseline levels of all the parameters, then it would be advisable to stop Boluoke® for at least 3-4 weeks prior to testing. However, this may not be feasible for high-risk patients.